Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 15, 2023

SELL
$50.95 - $55.2 $1,069 - $1,159
-21 Reduced 50.0%
21 $1,000
Q3 2022

Nov 14, 2022

BUY
$37.22 - $100.5 $1,563 - $4,221
42 New
42 $2,000
Q2 2022

Aug 12, 2022

SELL
$48.99 - $57.46 $7,103 - $8,331
-145 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$47.89 - $53.12 $1,819 - $2,018
-38 Reduced 20.77%
145 $7,000
Q1 2021

May 14, 2021

BUY
$45.46 - $50.51 $8,319 - $9,243
183 New
183 $9,000
Q3 2020

Nov 18, 2020

SELL
$49.47 - $53.77 $7,173 - $7,796
-145 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$44.25 - $50.86 $33,408 - $38,399
-755 Reduced 83.89%
145 $7,000
Q3 2019

Nov 12, 2019

SELL
$40.34 - $46.64 $1,936 - $2,238
-48 Reduced 5.06%
900 $42,000
Q2 2019

Aug 15, 2019

BUY
$40.43 - $44.3 $38,327 - $41,996
948 New
948 $41,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $120B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Stonebridge Capital Advisors LLC Portfolio

Follow Stonebridge Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonebridge Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonebridge Capital Advisors LLC with notifications on news.